Challenges and Solutions for Advancing Diversity, Equity and Inclusion
Wednesday, May 15, 2024, 10:30 AM - 11:15 AM
Inadequate diversity in clinical trials is a significant issue that has far-reaching consequences on the quality, cost, and safety of healthcare interventions. Recognizing and addressing the barriers to diverse participation is crucial for ensuring that clinical research is representative and applicable to all patient populations. The panel will address the challenges of achieving patient diversity in clinical research, explore the potential consequences of inadequate representation, and discuss strategies to foster patient diversity in the early stages of study development.
• Emery Brandy - Senior Manager-Client Delivery - WCG Clinical (Facilitator)
• Wunmi Bakare - Patient and Advocacy Trailblazer (Speaker)
• Stacey Bledsoe - Head of Global Clinical Trial Diversity and Inclusion - Gilead (Panelist)
• Brittany Gerald - Associate Director, Clinical Trial Diversity & Inclusion - Moderna (Panelist)
• William Maybee - Community Relations Coordinator - Roswell Park (Panelist)
• Wunmi Bakare - Patient and Advocacy Trailblazer (Speaker)
• Stacey Bledsoe - Head of Global Clinical Trial Diversity and Inclusion - Gilead (Panelist)
• Brittany Gerald - Associate Director, Clinical Trial Diversity & Inclusion - Moderna (Panelist)
• William Maybee - Community Relations Coordinator - Roswell Park (Panelist)